On this episode of Stock Movers:
- Capital One (COF) shares sink after President Donald Trump called on credit-card companies to cap interest rates at 10% for a year. The cap proposed by the president could wipe out earnings from cards for a year and ruin card economics, according to Mike Mayo, an analyst at Wells Fargo & Co.
- Abercrombie & Fitch (ANF) shares sank after holiday sales disappointed investors, helping spark a selloff in retail stocks. The company now expects fourth-quarter sales growth of around 5%, the mid-point of its prior range, and didn’t raise its outlook.
- Medline (MDLN) shares rise as analysts started coverage on the medical supplier, which went public last month. Firms are largely positive on its prospects.

On this episode of Stock Movers: - Capital One (COF) shares sink after President Donald Trump called on credit-card companies to cap interest rates at 10% for a year. The cap proposed by the president could wipe out earnings from cards for a year and ruin card economics, according to Mike Mayo, an analyst at Wells Fargo &amp; Co. - Abercrombie &amp; Fitch (ANF) shares sank after holiday sales disappointed investors, helping spark a selloff in retail stocks. The company now expects fourth-quarter sales growth of around 5%, the mid-point of its prior range, and didn&rsquo;t raise its outlook. - Medline (MDLN) shares rise as analysts started coverage on the medical supplier, which went public last month. Firms are largely positive on its prospects.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Capital One Sinks, Abercrombie & Fitch Tumbles, Medline Rises on Analyst Initiations

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f1f2098f-f962-4584-96ed-b3d000fb9b9d/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Asian cable stocks, including Furukawa Electric and Yangtze Optical Fibre & Cable, climb after Verizon signs a multi-billion dollar supply agreement with Corning.
- Nintendo’s stock dropped as much as 3.7%, the most since July 31, after its online Direct event held to mark the 40th anniversary of Legend of Zelda provided no positive surprises.
- Energy-related stocks rose as Brent crude extended its rally to near $100 per barrel after US forces destroyed five Iranian tankers carrying crude oil on Tuesday. Shares in Woodside soared as much as 2.6%

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Asian cable stocks, including Furukawa Electric and Yangtze Optical Fibre &amp; Cable, climb after Verizon signs a multi-billion dollar supply agreement with Corning. - Nintendo&rsquo;s stock dropped as much as 3.7%, the most since July 31, after its online Direct event held to mark the 40th anniversary of Legend of Zelda provided no positive surprises. - Energy-related stocks rose as Brent crude extended its rally to near $100 per barrel after US forces destroyed five Iranian tankers carrying crude oil on Tuesday. Shares in Woodside soared as much as 2.6%

Yangtze Climbs, Nintendo Slides, Woodside Soars

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/795ac765-70a3-4b5f-ab4e-b4c00069c93f/transcript

Today's biggest winners and losers in the stock market, a look at the notable movers: 
On this episode of Stock Movers:

- Chime Financial (CHYM) struck a deal to buy Stride Bank for $590 million in cash, with Stride to become Chime Bank, a wholly owned subsidiary. Chime will consolidate its banking activities at Stride and seek to keep the bank's assets below $10 billion for the "foreseeable future". The deal is expected to be completed in the first half of 2027, subject to regulatory approvals, and Chime anticipates it will see $100 million in net synergies from the deal.

- Boston Scientific (BSX) and Stryker (SYK) shares fell after the companies said they are dealing with the repercussions of separate cyber attacks. The cyber attacks curtailed the companies' ability to get products to customers and dented sales, with damage that could last for months. Both companies sell medical devices and are working to recover from the cyber incidents, with Boston Scientific's full operational recovery timeline remaining uncertain. Boston Scientific fell as much as 4.9% Tuesday in New York, while Stryker was down as much as 9.1%.

- Shares of Compass Pathways climb 3.9% after the bell after Bloomberg reports that a psychedelics developer is expected to be tapped for a top FDA drug role.

Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: - Chime Financial (CHYM) struck a deal to buy Stride Bank for $590 million in cash, with Stride to become Chime Bank, a wholly owned subsidiary. Chime will consolidate its banking activities at Stride and seek to keep the bank's assets below $10 billion for the "foreseeable future". The deal is expected to be completed in the first half of 2027, subject to regulatory approvals, and Chime anticipates it will see $100 million in net synergies from the deal. - Boston Scientific (BSX) and Stryker (SYK) shares fell after the companies said they are dealing with the repercussions of separate cyber attacks. The cyber attacks curtailed the companies' ability to get products to customers and dented sales, with damage that could last for months. Both companies sell medical devices and are working to recover from the cyber incidents, with Boston Scientific's full operational recovery timeline remaining uncertain. Boston Scientific fell as much as 4.9% Tuesday in New York, while Stryker was down as much as 9.1%. - Shares of Compass Pathways climb 3.9% after the bell after Bloomberg reports that a psychedelics developer is expected to be tapped for a top FDA drug role.

Chime, Boston Scientific Falls, Compass Pathways Rises

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/f0d2c8af-f948-4621-b519-b4bf015bf0e0/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Carol Massar and Tim Stenovec
- Bloom Energy (BE) and Everpure shares are rising on Tuesday after S&P Dow Jones Indices said the companies will join the S&P 500 Index, effective prior to the open of trading on Sept. 21.

- Amgen (AMGN) declines after BMO Capital Markets cut its recommendation on the pharmaceutical company to market perform from outperform, while shares in biotechnology companies slumped after Novartis suffered its third clinical-trial setback in a week.

- Constellation Brands (STZ) shares are down as much as 3.7%, to the lowest intraday since April 2020, as CEO Nick Fink and EVP/CFO Garth Hankinson speak at the Barclays consumer conference

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Carol Massar and Tim Stenovec - Bloom Energy (BE) and Everpure shares are rising on Tuesday after S&amp;P Dow Jones Indices said the companies will join the S&amp;P 500 Index, effective prior to the open of trading on Sept. 21. - Amgen (AMGN) declines after BMO Capital Markets cut its recommendation on the pharmaceutical company to market perform from outperform, while shares in biotechnology companies slumped after Novartis suffered its third clinical-trial setback in a week. - Constellation Brands (STZ) shares are down as much as 3.7%, to the lowest intraday since April 2020, as CEO Nick Fink and EVP/CFO Garth Hankinson speak at the Barclays consumer conference

Closing Bell: Bloom Energy Gains, Amgen Lower, Constellation Brands Declines

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/49e1010e-cb89-4914-9558-b4bf014bd718/transcript

Capital One Sinks, Abercrombie & Fitch Tumbles, Medline Rises on Analyst Initiations

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips